Difference between revisions of "Alprazolam"
From Psychiatrienet
| (2 intermediate revisions by the same user not shown) | |||
| Line 15: | Line 15: | ||
| avail_ref = <ref name="informatorium">{{KNMP|alprazolam}}</ref> | | avail_ref = <ref name="informatorium">{{KNMP|alprazolam}}</ref> | ||
| halflife = 12-15 | | halflife = 12-15 | ||
| − | | halflife_ref = <ref | + | | halflife_ref = <ref>{{pts|1467|1|1}}</ref><ref name="drugs">{{DRUGSCOM|alprazolam}}</ref> |
| − | |||
| − | |||
| administration = O | | administration = O | ||
| administration_ref = <ref name="drugs" /> | | administration_ref = <ref name="drugs" /> | ||
| Line 23: | Line 21: | ||
| dose_ref = <ref name="informatorium" /><ref name="drugs" /> | | dose_ref = <ref name="informatorium" /><ref name="drugs" /> | ||
| DDD = 1 | | DDD = 1 | ||
| − | | DDD_ref = <ref>{{WHOCC| | + | | DDD_ref = <ref>{{WHOCC|N05BA12}}</ref> |
| ctox = 75 | | ctox = 75 | ||
| ctox_ref = <ref>{{Toxicology|29}}</ref> | | ctox_ref = <ref>{{Toxicology|29}}</ref> | ||
| − | | <includeonly> | + | | <includeonly> isswitch = 1</includeonly> |
}} | }} | ||
Latest revision as of 18:37, 23 April 2010
| alprazolam | |||||||||||||||||
| Type | benzodiazepine | ||||||||||||||||
| Group | benzodiazepine | ||||||||||||||||
| links | |||||||||||||||||
| ATC-code | N05BA12 | ||||||||||||||||
| PubChem | 2118 | ||||||||||||||||
| PubMed | alprazolam | ||||||||||||||||
| Drugs.com | alprazolam | ||||||||||||||||
| Kompas (Dutch) | alprazolam | ||||||||||||||||
| Wikipedia | alprazolam | ||||||||||||||||
| |||||||||||||||||
"-15" can not be assigned to a declared number type with value 12.
alprazolam is a benzodiazepine in the group benzodiazepine.
- ↑ WHO Collaborating Centre for Drug Statistics Methodology ATC=N05BA12
- ↑ 2.0 2.1 KNMP; Informatorium Medicamentorum 2023; Monografie "alprazolam" (Dutch)
- ↑ 3.0 3.1 3.2 Drugs.com alprazolam
- ↑ NVZA; Toxicology.org; Monografie 29 (dutch)
- ↑ KNMP; Informatorium Medicamentorum 2009; Inleidende tekst "Benzodiazepineagonisten" (dutch)
- ↑ The Lundbeck Institute; Psychotropics; Terminal Plasma Half-lives
